1. 2020
  2. Long-term safety and effectiveness of natalizumab treatment in clinical practice: 10 years of real-world data from the Tysabri Observational Program (TOP)

    Tysabri Observational Program (TOP) Investigators, Butzkueven, H., Kappos, L., Wiendl, H., Trojano, M., Spelman, T., Chang, I., Kasliwal, R., Jaitly, S., Campbell, N., Ho, P-R. & Licata, S., Jun 2020, In : Journal of Neurology, Neurosurgery and Psychiatry. 91, 6, p. 660-668 9 p., 0.

    Research output: Contribution to journalArticle

  3. Gut microbiome variation is associated to Multiple Sclerosis phenotypic subtypes

    Reynders, T., Devolder, L., Valles-Colomer, M., Van Remoortel, A., Joossens, M., De Keyser, J., Nagels, G., D'hooghe, M. & Raes, J., Apr 2020, In : Annals of clinical and translational neurology. 7, 4, p. 406-419 14 p.

    Research output: Contribution to journalArticle

  4. Correction to: Detecting neurodegenerative pathology in multiple sclerosis before irreversible brain tissue loss sets in

    Van Schependom, J., Guldolf, K., D'hooghe, M. B., Nagels, G. & D'haeseleer, M., 2020, In : Translational neurodegeneration. 9, p. 1-1 1 p., 3.

    Research output: Contribution to journalComment/debate

  5. Spatiotemporal and spectral dynamics of multi-item working memory as revealed by the n-back task using MEG

    Costers, L., Van Schependom, J., Laton, J., Baijot, J., Sjøgård, M., Wens, V., De Tiège, X., Goldman, S., D'Haeseleer, M., D'hooghe, M. B., Woolrich, M. & Nagels, G., 2020, In : Human Brain Mapping. 41, 9, p. 2431-2446 16 p.

    Research output: Contribution to journalArticle

  6. 2019
  7. Stronger Correlations between Neurophysiological and Peripheral Disease Biomarkers Predict Better Prognosis in Two Severe Diseases

    Gidron, Y., De Couck, M., Reynders, T., Marechal, R., Engelborghs, S. & D'hooghe, M., 20 Dec 2019, In : Journal of Clinical Medicine. 9, 1, 26.

    Research output: Contribution to journalArticle

  8. Perceived neuropsychological impairment inversely related to self-reported health and employment in multiple sclerosis

    D'hooghe, M. B., De Cock, A., Benedict, R. H. B., Gielen, J., Van Remoortel, A., Eelen, P., Van Merhaegen, A., De Keyser, J., D'Haeseleer, M., Peeters, E. & Nagels, G., Dec 2019, In : European Journal of Neurology. 26, 12, p. 1447-1454 8 p.

    Research output: Contribution to journalArticle

  9. The Impact of Cognitive Dysfunction on Locomotor Rehabilitation Potential in Multiple Sclerosis

    Denissen, S., Cock, A. D., Meurrens, T., Vleugels, L., Remoortel, A. V., Gebara, B., D’Haeseleer, M., D’Hooghe, M. B., Schependom, J. V. & Nagels, G., 6 Nov 2019, In : Journal of central nervous system disease. 11, p. 1-5

    Research output: Contribution to journalArticle

  10. Altered transient brain dynamics in multiple sclerosis: Treatment or pathology?

    Van Schependom, J., Vidaurre, D., Costers, L., Sjøgård, M., D'hooghe, M. B., D'haeseleer, M., Wens, V., De Tiège, X., Goldman, S., Woolrich, M. & Nagels, G., 1 Nov 2019, In : Human Brain Mapping. 40, 16, p. 4789-4800 12 p.

    Research output: Contribution to journalArticle

  11. Fluoxetine in progressive multiple sclerosis: The FLUOX-PMS trial

    FLUOX-PMS Study Group & Bissay, V., Nov 2019, In : Multiple Sclerosis. 25, 13, p. 1728-1735 8 p.

    Research output: Contribution to journalArticle

Previous 1 2 3 4 5 6 7 8 9 Next

ID: 184707